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INTRODUCTION 
         Breast is an important feature of female anatomy particularly representing 
feminity.  Contemporary  concepts  of female  beauty and feminity necessitates 
the breast to be esthetically acceptable in all the situations. It not only 
symbolises feminity, mammary glands are also important for the survival of the 
newborn and thus of the species and portrays the womanhood. 
          Any change within the breast that comes into notice in a female has a 
significant impact on her  well being.  So, its more of a psychological and 
emotional concern. Rather than disease per se , its the fear of malignancy makes 
her more apprehensive and anxious.  
         Though breast cancer being centered in any case with a breast lump, every 
physician has to remember that benign lesions are more common than 
malignancy.  Enough attention has not been given for the benign breast 
disorders as much as it was deserved.  We have only few papers, studies 
discussed about this subject.   
          Benign tumours of the breast is 4 to 5 times more common than 
malignancy.  Benign breast diseases are common disorder, in up to 30% of 
women will suffer from benign breast diseases requiring treatment at some time 
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or the other in their lifetime.
1 
 Over 80% of the breast problems present as pain 
and or lumps in the breast. 
         The ratio of malignant : benign breast diseases (BBD) is approximately 1 : 
10 in the west.
2 
         No comprehensive Indian stastics are available. But it is suspected that 
position may be similar to that obtaining in the west. No age is barred. Breast 
cancer risk increases with age and same follows a reverse trend in BBD which 
is primarily seen in reproductive age group. Familial incidence of BBD 
explained possibly related to a shared environment and lifestyle. The BBD is 
largely hormone induced and diets such as methylxanthines (eg:coffee, tea, 
cola) are attributed in its causation.  
        The nomenclature of BBD is very confusing. This is because over the last 
century a variety of clinicians and pathologists have chosen to describe  a 
mixture of physiological changes according to a variety of clinical, pathological 
and etiological terminology. As well as leading to confusion,  patients were 
unduly alarmed or overtreated by ascribing a pathological name to a variant of 
physiological development. 
         The term benign breast disease has been used as a portmanteau into which 
all breast disease excluding malignancy have been cast, thereby blurring the 
distinction between a variety of benign breast conditions. To sort out this 
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confusion, a new system(aberration of normal development and 
involution)ANDI has been described by the Cardiff breast clinic. 
         Breast lump brings about anxiety and worry to the patient, as do tumours 
of the breast.  There are deep psychogenic reasons, which make the thought of 
loss of the breast terrifying to the average woman. As cancer consciousness has 
taken deeper root among the patients, as well as in surgeons, all the benign 
tumours are surgically removed and  subjected  for  histopathological  study 
where unnecessary surgery can be avoided, but surgery should not withheld in 
apprehensive patients and in those having pre malignant tumours.                          
         As the surgery is not only curative but also safeguard against development 
of malignancy in them in future. It relieves anxiety and apprehension of the 
cancer conscious patients. The exact relationship between the benign and 
malignant tumour is yet to be established. 
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REVIEW OF LITERATURE 
HISTORICAL ASPECTS : 
           The tumours of the breast, with its uncertain cause, has captured the 
attention of the physicians throughout the ages. 
            Huang Di, the yellow Emperor in 2698 BCE wrote the Nei Jing, the 
oldest treatise of medicine, gives the first description of tumours of breast. 
Imhotep, an Egyptian physician( 2650 BCE), designed the first pyramid and 
deified as god of healing. The early Egyptian documented many cases of breast 
tumours including abscesses,trauma and infected wounds.  The references were 
acquired by Edwin Smith in 1862 and presented in New York historical 
society
3
.  Writings from India and Assyria that date from the same period also 
mention breast tumours .  
          The scientific method and clinical advancement of of medicine is credited 
to Hippocrates,  the Father of medicine (5
th
 century BC) was the first to 
distinguish benign from malignant breast neoplasm.  In his work on “disease of 
women” descries the origin of the hard tumours of the breast and value of 
medical, surgical and cautery treatment in the breast tumours and he believed 
that knife can cure the tumour which is incurable by surgery. The Greek 
physician and surgeon, Leonoides of Alexandria (180 AD) credite the first 
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operative treatment for breast tumours and used the sign of the retraction of 
nipple to differentiate  malignant from benign tumours . 
          Attossa, daughter of cyrus concealed a tumour in her breast for a long 
time till it grew big and ulcerated.  When she was sent to Demoncedus a famous 
physician, who is said to have cured her breast tumour. This case may be a 
benign tumour of the breast. The method of treatment is not revealed
27.
. 
          The excision of benign tumours of the breast was recommended in a 
telescoping view where they could change malignant by „Mercus Aurelins 
severimens‟(1654). 
        Lorenz Heister (b. 1683) described mastectomy for cystosarcoma. Alfred-
Armand-Louis-Marie Velpaeu(b.1795), professor of clinical surgery at Paris, in 
his Treatise on disease of breast claimed to described benign breast tumour
4
.  
Sir Astley Cooper  published the Illustration of the Diseases of the breast in 
1829 clearly differentiated fibroadenoma from chronic cystic mastitis. 
        De Chauliac emphasized the need for wide excision of breast tumours. 
Brodie is thought to have provided the first clear description of cystic disease in 
1846. Cheatale and Cutler  were the first to acknowledge that nodularity of the 
breast was not necessarily pathologic, but occurred regularly under 
physiological conditions such as menstruation
7
.  
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       Geschictter et al and Patey continued to differentiate among the clinical 
syndromes, pain, nodularity and cystic diseases
8
. Haagensen in his classic book 
on breast maintained a distinction between pain, physiological nodularity and 
gross cystic disease
9
. Birkett (1850), Velpeau (1856), Bryant (1887) published 
description of benign breast disease and clearly distinguished between cystic 
disease.  
        Cheatale 6 and Cutler (1931) were the first to acknowledge that nodularity 
of the breast was not necessarily pathologic, but occurred regularity under 
physiological conditions such as menstruation(grosscyst) and what they 
described as pain syndrome. 
          R. Egan(1962) described  mammographic imaging in which difference 
between benign and malignant tumours was made without the aid of clinical 
findings
5
. Various authors like L.E. Hughes, Parks and Sandison in 1960, 
demonstrated that the changes commonly described as fibroadenosis were 
widely distributed in patients who had not claimed to be symptomatic or 
demonstrated overt disease.  
        Benign proliferation of the breast are often considered as aberrations of 
normal development and involution. The cyclical changes due to variations in 
estrogen and progesterone results in increased mitosis around days 22 – 24 of 
the menstrual cycle but apoptosis restores the balance across the cycle.  
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           A new nomenclature ANDI (Aberrations of normal development and 
involution) was put forward in a National breast conference in Cardiff in 1982. 
Hughes et al(1987)  proposed  ANDI(aberration of normal development and 
involution) classification and its accepted by a multinational, multidisciplinary 
working party which is now universally accepted. This concept allows 
conditions of the breast to be mapped between normality, through benign 
disorders to benign breast disease
6
. 
EMBRYOLOGY: 
         By 5-6 weeks – mammary ridges or milk ridges(milk streak/galactic band) 
occurs along the line which is stretched from the axilla to the groin. 
         By 7th week- the galactic band in the region of thorax form the mammary 
bud and the rest of the portion regresses. The thickening  in mammary 
bud(Milkhill stage), followed by invagination into chest wall mesenchyme(disk 
stage) with a tridimensional growth(globular stage). 
         At 10 – 14 weeks of gestation, invasion into chest wall and the ridge gets 
flattened(cone stage).The cell of mesenchyme differentiate into the smooth 
muscles of nipple and areola with simultaneous developing epithelial 
bud(Budding stage). The buds branches and results in the formation of  multiple 
epithelial strips(branching stage).  
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         Almost by 16 weeks, the strips represents the future secretory alveoli. The 
secondary mammary changes occurs by formation of hair follicle, sebaceous 
gland and sweat gland elements. Only sweat gland develops fully at this time. 
The above changes in breast development is independent of hormonal influence. 
          The placental sex hormones will enter the fetal circulation by 3rd 
trimester of pregnancy.  This acts as a stimulus for the epithelial strips to 
canalize(canalization stage) and this stage keep happening from 20th to 32nd  
weeks.   
          Near term, 15–25 mammary ducts  formed with coaelescence of ducts. By 
32 – 40 weeks, parenchymal differentiation occurs and lobular alveolar 
structure contains colostrum(end vesicle stage). All these results in four fold 
increase in gland mass, nipple areolar complex develops with pigmentation. The 
mammary tissue secretes colostral milk(witch‟s milk) once stimulated and 
expressed in postpartum(4 – 7 days) via nipple in most of the neonates in both 
sexes. 
             And this colostral secretion will decline by 3 – 4 weeks period due to 
involution of the breast which occurs as a result of placental hormones 
withdrawal. The end vesicles are further canalized and develop into ductal 
structures by additional growth and branching, during early childhood period. 
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ANATOMY : 
               Diseases occurring in the breast are best understood in the context of 
its normal anatomy. Though the breast is present in both males and females but 
functionally important in later. Breast is an adapted sweat glands invested 
within the superficial fascia that divides into two layers. The anterior layer 
separates the relatively small subcutaneous fat lobules and the larger lobules of 
mammary fat. The posterior layer of superficial fascia rests on the deep fascia 
derived from the pectoralis major and serratus anterior. The condensations of 
fibrous tissue between the two layers of fascia(suspensory ligaments of Cooper)  
divides the breast into lobes. Mammary glands contains abundance of adipose 
tissue and dense connective tissue. The breast size is determined by the adipose 
tissue content within the breast. It extends vertically from 2nd to 6th ribs and 
horizontally from sternal edge medially and almost to midaxillary line laterally. 
The breast tissue prolonged towards the axilla as the “ tail of spence”.  The 
retromammary space is the loose areolar connective tissue that is present 
between breast and fascia. 
NIPPLE AND AREOLA : 
                It projects centrally placed,conical or flattened and is at the level of 
the 4th intercostal space. Colour varies from pink to light or dark brown and 
hairless. It has sweat glands and small sebaceous glands give rise to uneven 
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surface produce known as Montogmery tubercles. Lactiferous ducts opens into 
its wrinkled tip of nipple via 15 – 20 minute orifices. 
LOBES OF THE BREAST: 
Each lactiferous duct opens into nipple, after draining the lobes of the breast. 
All these lobes are arranged radially. 
                                       Lobe contains 20 – 40 lobules 
                                                             ↓ 
          Lobules contain 10 – 100 alveoli  (tubulosacular secretory units)   
                                                               ↓ 
                                                  Terminal duct 
                                                               ↓ 
                                                  Segmental duct 
                                                             ↓ 
                                           Collecting duct(15 – 20) 
                                                             ↓ 
                               Opens through separate orifice in nipple 
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                             The detailed anatomical knowledge of larger duct system and 
terminal duct lobular unit(TDLU) helps in the exact pathological location in 
various disorders of breast. 
       For example: 
                          a)   Larger duct : benign papilloma 
                             b)  TDLU: Fibroadenoma in developmental phase 
                             c) Cyst  and sclerosing adenosis in involutional phase 
                             d) Intralobular –terminal duct: carcinoma 
 BLOOD SUPPLY : 
The main blood supply is via the second perforating branch of the internal 
mammary and lateral thoracic branches of the axillary artery.  
 Arterial supply : 
1.  From the axillary artery via its lateral thoracic and acromiothoracic branches.  
2.  From the internal  mammary  artery via its perforating branches, pierce the 
first to the fourth intercostal spaces, then traverse the pectoralis  major to reach 
the breast along its medial edge. The first and second perforators  are the largest 
of these branches.  
3.  From the intercostal arteries via their lateral perforating branches  relatively  
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unimportant source. 
Venous drainage: 
                The entire venous network is devoid of valves in the breast.  
The axillary, internal thoracic and the third to fifth intercostal veins drain the 
mammary gland. Venous system consists of superficial and deep venous 
plexuses. They anastamose with the interglandular system and in the more 
superficial plane there are subdermal veins and  this special network around 
areola constitute the “circle of Haller”.From here is formed a plexus with a very 
wide mesh, the “Subcutaneous plexus of Haller” that inturn drains into the 
superficial veins of the following regions, 
1. Above into superficial cervical plexus (anterior and external jugular 
veins) 
2. Laterally into cephalic vein via the thoracoacromial vein 
3. Below into the superficial veins of the abdominal wall notably to 
superficial thoraco-epigastric by communication with the plexus of the 
opposite breast. 
Deep venous drainage accompanies the arterial flow. Intercostal veins course 
via azygous and vertebral veins into superior vena cava. The internal thoracic 
perforators empty into the innominate veins. Pectoral perforators flow into the 
lateral thoracic vein reaches the axillary vein 
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        A rich subareolar venous plexus drains via the intercostal, internal 
mammary and axillary veins.  The distribution of major lymphatics follows the 
blood supply. 
        The importance of venous drainage of breast, is being  the fact that 
lymphatics  follow the vascular pathway and make the whole point clear the 
various mode of metastasis that occurs in breast carcinoma. 
LYMPHATIC DRAINAGE: 
        The lymphatics of the breast are thin-walled, valveless vessels that drain 
unidirectionally except when obstructed by inflammatory or neoplastic disease. 
The superficial subareolar lymphatic plexus drains primarily the skin over the 
breast,  nippleareola complex. This plexus is interconnected with the deep 
lymphatic plexus, which drains most of the breast parenchyma. The flow 
commences  from the superficial to deep plexus and from the subareolar plexus 
through the lymphatic vessels of the lactiferous duct to the perilobular and deep 
subcutaneous plexus. 
          Approximately 3 percent of the lymph from the breast is estimated to 
flow to the internal mammary chain, whereas 97 percent  flows to the axillary 
nodes. 
These axillary nodes are divided into three groups according to their 
relationship to the pectoralis minor muscle .(Anatomic level) 
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Level 1, nodes lying below the pectoralis minor 
Level 2, nodes lying behind the pectoralis minor 
Level 3, nodes lying above the pectoralis minor 
 Drainage of lymph nodes is sequential  from level 1 to levels 2 and 3, and even 
drainage in retrograde fashion to the subscapular and interpectoral groups of 
nodes also noted.  A small amount of lymph drains from the superior aspect of 
the breast directly to the apical nodes in level 3, bypassing nodes in levels 1 and 
2. About 25% of lymph (mainly from the medial half of the breast) drains to the 
internal mammary nodes in the second, third and fourth intercostal spaces. 
            The axillary lymph nodes ( 20–30) drain not only the lymphatics  of  the 
breast  but also those of the pectoral region, upper abdominal wall and the upper 
limb  
and are arranged in five groups.  
1   Anterior 
2   Posterior 
3   Lateral  
4   Central  
5   Apical (through which all the other axillary nodes drain) 
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        Lymphatic capillaries fuse to form channels, finally  terminates in thoracic 
duct in left side and empties into left subclavian vein whereas the right 
lymphatic duct into right subclavian vein.  
Nerve supply: 
       Nervous supply of breast by the anterior and lateral cutaneous branches of 
4
th
 to 6
th
  intercostal nerves which carry sensory and sympathetic efferent fibers.  
Lateral cutaneous ramus of T4 primarily supplies the nipple. This forms an 
extensive nerve plexus within the nipple, its sensory fibers terminating close to 
epithelium as free endings, meissener‟s corpuscles and merkel disc  endings. 
PHYSIOLOGY OF BREAST:   
          Breast structure varies with age, time in menstrual cycle, pregnancy and 
lactation. It is under the control of neuro-endocrinal system. Hormones such as 
oestrogen and  progesterone play a major role. Three major types of 
physiological changes are seen in the breast physiology. They are : 
a. Growth and involution of the breast related to age 
b.  Changes that are associated with menstrual cycle 
c. Changes that occur due to pregnancy and lactation 
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 Pre-pubertal:  
         In the neonates there are lactiferous ducts but no alveoli, and until puberty 
little branching of ducts occur, slight mammary enlargement being due to 
growth of fibrous  
stroma and fat.  
During menstrual cycle:  
         In the follicular phase i.e., day 3 to day 14 the stroma is less 
dense,changes within the lumen of duct with no secretion. In the luteal phase 
i.e., day 15 to day 25, increase in the stromal density, the ducts have open lumen 
containing secretion. Due to prolactin and increased endogenous oestrogen  has 
found to exert histamine like action and thereby increasing  microcirculation 
blood flow,  3 days prior to menstruation. 
         Due to increasing interlobular edema ,females has fullness of 
breast(increased breast volume) in premenstrual period.  Breast volume reaches 
its minimum at 5 – 7 days after menstruation.  
 
[Type text] 
 
 
FIG.1:  Depicts the changes in breast development 
In pregnancy and suckling : 
           Due to raise in placental  estrogen and progesterone, the ducts increase in 
number and dimension, alveoli proliferate and secretes milk resulting in 
expansion of  alveoli.  
Post-lactational breast : 
         The secretary tissue undergo involution, but the ducts and alveolus never 
returns completely to pre-pregnant stage. 
Menopause : 
         There will be regression of epithelial structures and stroma. The duct 
system remains, but the lobules shrink and collapse.  
 
[Type text] 
 
PATHOPHYSIOLOGY : 
          The aetiology of benign breast disease is not well established, evidence 
from both animal and human studies is suggestive of a hormonal role in the 
pathophysiology of benign breast disease. By experiments on animals, 
development of benign mammary lesions following administraton of oestrogen 
has been noted. Investigators have found abnormally high oestrogen levels or an 
imbalance between oestrogen and progesterone levels among women with 
benign breast disease. 
MOLECULAR BIOLOGY : 
            Normal mammalian breast development depends on a combination of  
local cell–cell interactions  and systemic mammotrophic hormones. The local 
cellular interactions mediated by growth factors (EGF,TGF-b,FGF), and Wnt 
gene families.TGF-a  both ductal growth and alveolar development. TGF-b may 
govern early ductal development along with development of alveoli. FGF-1 and 
FGF-2 are proven angiogenic factors promoting mammary ductal development 
during sexual maturity. FGF-1 up-regulated in ductal epithelium. FGF-2 is 
expressed in the mammary stroma. Wnt-1, identified as an oncogene found to 
be expressed in mammary glands of transgenic mice. The growth factors with 
regulated expression acts in conjunction with mammotrophic hormone and 
exhibit mammary differentiation, its growth as well as regression. Further 
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investigation on this will help us in better understanding of breast development 
and mammary tumorogenesis. 
  BENIGN BREAST DISEASES : 
          Diseases of breast have varied spectrum ranging from deviation from the 
apparently normal to the serious form such as malignancy. Benign breast 
diseases have similar presentation beginning from disorder to a well established 
disease process. 
 ABERRATION OF NORMAL DEVELOPMENT AND INVOLUTION 
(ANDI) : 
           The aberration of normal development & involution(ANDI)classification 
of BBD comprises the framework for benign conditions of breast that 
encompasses both pathogenesis & the degree of abnormality.                                
                            The ANDI classification was accepted internationally since 
1992. 
The principles of classification are: 
1.Benign disorders are related to the normal processes of reproductive life. 
2. The spectrum ranges from normal to aberration to sometimes disease. 
3. The distinction between normal and abnormal is pragmatic. 
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 4. The ANDI concept is a unifying concept of symptoms,signs,histology and 
physiology. 
 5. The classification is not comprehensive.  
It does not include infective/traumatic diseases and male breast pathology is not 
explicit. 
ANDI(ABERRATION OF NORMAL DEVELOPMENT AND 
INVOLUTION) : 
                          The categorisation of breast disorders has been made more 
appropriate by relating them to the aberrations of the following normal 
processes.  
1.Development  
2.Cyclical change 
3.Involution 
                                               DISORDER OF DEVELOPMENT 
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TABLE 1 :  DISORDERS OF DEVELOPMENT 
Physiological 
state of breast 
Normal event Benign disorder Turned out to be 
a disease 
 
        
Development 
a)nipple eversion 
b)Lobulardevelopment 
c)Stromaldevelopment 
Nipple inversion 
Fibroadenoma 
Adolescent 
hypertrophy 
Subareolar 
abscess 
Giant FA 
 
Gigantomastia 
 
 FIBROADENOMA : 
       It is considered as an Aberration of normal lobular development. Most 
important pathological aspect is its epithelial cells arranged in  connective tissue 
stroma. Depending on the stromal component it is classified as 
1.Pericanalicular type and  
2.Intracanalicular type 
         Molecular biology studies shows that fibroadenomas are polyclonal in 
keeping with hyperplasia and phyllodes tumor are monoclonal. They exhibit 
hormonal influence, sas observed in normal lobules and thus they lactate during 
pregnancy. During involution, replaced by hyaline connective. Usually,they can 
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reach upto  3 cm, growth beyond 5cm was very uncommon and  regarded as 
giant fibroadenoma. Fibroadenoma fits well into the ANDI classification.  
Small fibroadenoma are “ normal” 
clinical fibroadenoma(1-3cm) are a “disorder” of normal process. 
Giant and multiple fibroadenomas  fit in the “disease”. 
        FA commonly occuring in women of age 15 to 25. It is smooth, rounded, 
firm to hard in consistency and freely mobile within the breast that why it is 
known as breast mouse and  lacks this characteristics features in elderly patients 
due to involute replaced by fibrosis. 
        The biological behaviour of FA is variable. Either it may regress, remains 
the same or grow progressively. 
        Treatment is by surgical excision of the lump, often removed to alleviate 
patient concern.  If, <25YRS, routine removal will be unnecessary, <35YRS 
conservative approach is recommended. Cytology is done every 3 months to 
rule out malignancy. Excision 
Of the fibroadenoma is  considered after 35 yrs. 
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   FIG.2: Fibroadenoma excision 
FIG.3: excised specimen 
      Studies have shown no malignany risk and supports conservative policy. 
The occurrence of carcinoma in FA is very rare and to till date only  96 cases 
totally documented in world literature. If the possibility of carcinoma arises 
from FA, the epithelial component can be blamed off. 
ADOLESCENT HYPERTROPHY:  
         Breast development  associated with gross stromal development. 
Pathogenesis not known and attributed to the hormonal basis. 
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      An excessively large breast is a disorder. Gigantomastia is the disease end 
of the spectrum. 
                                         
DISORDERS OF CYCLICAL CHANGE 
TABLE 2 : DISORDER OF CYCLICAL CHANGE 
Physiological state 
of breast 
Normal event Benign disorder Turned out to be a 
disease 
 
        Cyclical 
change 
 
Hormonal activity 
 
 Mastalgia(cyclical)& 
       nodularity 
 
 
 
   Severe mastalgia 
 
MASTALGIA AND NODULARITY:  
                           They occur along with normal event such as enlargement of 
breast during premenstruation phase and postmentrual involution of breast. 
Painful nodularity that persist more than 1 week of the menstruation is 
considerd as a disorder. The underlying physiologic abnormality is the 
increased release of prolactin from pituitary gland by hypothalamic pituitary 
[Type text] 
 
axis stimulation
10
 and associated with increased caffeine ingestion and ,decresed 
essential fattyacid intake. 
Pathology: 
Fibrosis→Cyst 
formation→Adenosis→Epitheliosis→Papillomatosis→Apocrine metaplasia. 
       Mastalgia can occur either cyclical or noncyclical and differentiation aided 
by the use of  daily breast pain chart. Cyclical Mastalgia with nodularity also 
called as mammary dysplasia, fibrocystic disease, schimmelbusch disease, 
hormonal mastopathy or fibroadenosis. 
        Females around the age of 30-40 years,esp in nulliparous. Usually bothered 
by extreme breast discomfort and mastalgia with nodularity in association with 
menstruation and  the same showing waxing and wanning pattern in relation to 
each menstrual cycle. Prof. Jeffcote has referred to these women as “frustrated 
multipara” and Hagensen has stressed the psychologic nature of the mastalgia 
recently. 
        Diffuse nodular tender swelling, bilateral involvement and predominantly 
affects the upper outer quadrant with no characteristic mammographic or 
pathological feature. Changes may resolve with next menstrual cycle. 
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         Aspiration cytology and Mammography are indicated in older women and 
if doubtful in younger women. 
Aim is to exclude malignancy and reassure the patient.  
Medical treatment: 
1. Evening primrose oil 
2. Bromocriptine 
3. Tamoxifen 
4. Danazol 
       Various studies has been reviewed on the treatment of mastopathy. The 
effectiveness of the treatment was more  promising with evening primrose oil, 
bromocriptine, danazol,  tamoxifen and low fat diet. The efficacy of  
norethisterone has yet to be proven. They bring about alteration in metabolism 
of lipid or serum prolactin. The  prolactin acts on  lipid metabolism and thereby 
hypothesised that cyclical mastopathy may be considered as a disorder of lipid 
metabolism
11
 
        The effectiveness of treatment with Tamoxifen in mastlagia has been more 
in favour of non cyclical than cyclical. Its usage in practice to mount its 
effectiveness in treatment of mastalgia has yet to be established.                                                   
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  DISORDERS OF INVOLUTION 
Table 3: DISORDERS OF INVOLUTION 
Physiological 
state of breast 
Normal event Benign disorder Turned out to be a disease 
 
        Involution 
a)lobular 
involution 
 
b)ductal 
involution 
 
c)epithelial turn 
over 
a)Macrocysts & 
sclerosing lesions 
b)Duct 
ectasia,nipple 
retraction 
c)Mild epithelial 
hyperplasia 
a)cystic disease 
 
b)Periductal 
mastitis/abscess/mammary 
duct fistula 
 
c)epithelial hyperplasia 
 with atypia 
 
CYST FORMATION:  ANI(Aberration of normal involution) of a lobule. 
       They are common in 7% of women in west. The mechanism is unclear.  It 
is explained that  involution of a lobular epithelium is dependent on the 
specialized stroma around it. If stroma involutes too quickly the epithelial acini 
remain and can form microcysts, precursors of macrocyst formation. One of 
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such with huge dimensions having a thin capsule-blue domed cyst of 
Bloodgood.  
       Cysts  originate from Terminal duct lobular unit (TDLU).  
        Apocrine metaplasia that occurs in the lining epithelium and cyst are 
almost never malignant. 
Types: 
1. Apocrine:  
The cyst characterised by secretory epithelium(Na : K < 3).  They are multiple 
in numbers(>5). The chance of recurrence is five times higher than other types.  
2. Flattened:  
They are lined by less active epithelium(Na : K >3). Fluid within the cyst  
resembles plasma. 
3.Mixed type:   
Increased incidence between 40-50 years of age and with prolonged use of 
HRT. Cyst are frequent. Usually single, not uncommon to be multiple and often 
painful. 
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The breast cyst are usually solitary. 
                                          50% - solitary  
                                          30%  - 2-5cyst   
                                    remaining>5 cysts  
             Smooth, tense on palpation, mobility not as pronounced as 
fibroadenoma. Once suspicion of cyst arises, Ultrasonogram of the breast is the 
investigation of choice and mammography prior to aspiration. 
     Subclinical cases suggest that they are disorder, not a disease requiring 
specific treatment. 
TREATMENT: 
a.Simple aspiration of the cyst 
b. Surgical excision-Indication : 
                 1. Blood stained aspirate 
                 2. Recurrent cyst formation 
                 3. residual lump after aspiration 
FOLLOW UP : 
The suspicion of malignancy arises in following situations: 
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1. If the cyst is complex 
2. If blood stained fluid aspirated from cyst 
3. Recurrence of cyst  
4. Even after aspiration, either radiologically(mammogram) or 
clinically evident 
residual within the cyst or with no change in density of the lesion 
after aspiration. 
INTRACYSTIC CARCINOMA ARE RARE (0.1%) 
        Vargas et al
13
 conducted the study to assess the nature and the occurence of 
malignancy in the clinically detected breast lesions that are cystic in nature. 
With the aid of ultrasonogram of the affected breast and by image guided 
biopsy, the study showed that majority of the breast cyst are benign in nature 
and the occurrence of malignancy was approximately 0.1 percent to 1.2 percent.   
        Bland
14
 and his colleagues in their study observed the role of USG breast 
is superior to mammography in defining the cystic lesions of breast.  
 
2.DUCT ECTASIA AND PERIDUCTAL MASTITIS :  
         Bloodgood  termed  it as “Varicocele tumour” of the breast, 1923. 
Fuggier called the condition as “mastitis obliteran”. The principal inflammatory 
cell present in periductal inflammation was the plasma cell and thereby it was 
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also been termed as  “plasma cell mastitis”, and other terminologies were 
Comedo mastitis, granulomatous mastitis according to its histology. Haagensen 
was the first to use the term duct ectasia. 
          Haagensen
15 
proposed that the primary event was dilatation of the duct. 
The secretions stagnate which contains fatty acid, inturn acts as a chemical 
irritant to the periductal tissue. The process continues to cause the resultant 
fibrosis, brings about contraction and nipple retraction.  
      Another theory states the above event in retrograde fashion. The primary 
event to occur  is the  Periductal mastitis, can results in damage and disruption 
of the muscular layer/elastic supporting lamina within the duct and results in 
secondary dilatation of the duct
16
.   
       In a recent prospective study of 14275 patients determined the inter 
relationship between Periductal mastitis and duct ectasia. As per the study, both 
conditions are not a sequential event in either way. They are of separate entities 
with respect to their etiology and  pathology
17
. The age group involved in both 
conditions does not coincide which complements to the observation made in the 
study.   
       Smoking is incriminated as a cause in periductal mastitis and not so in duct 
ectasia as per the recent studies.  Cigarette  smoke substances are absorbed 
orally can damage the duct walls. Organisms such as Staphylococcus aureus or 
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anaerobic organisms(Bacteriodes and anaerobic streptococci) affects the 
damaged duct walls and in later date mounts the infection. 
       Duct ectasia  is  common among  postmenopausal breast and its a part of 
normal  involutional process where as periductal mastitis occurs in a younger 
age group. 
       Variable clinical presentation and at the same time they are well 
recognised. Non cyclical mastalgia, paste- like material discharge per nipple, 
felt as lump in the subareolar region, retraction of nipple(slit-like) and further 
complicated by recurrent abscess and fistula formation. 
Investigation:  
FNAC to confirm the diagnosis. Cytological conformation not always possible.  
Treatment: 
a.  Duct ectasia often improves without treatment.  
b.  Antibiotic course may be helpful with a symptomatic analgesic 
treatment. 
c.  If none of these works , surgical excision of all affected ducts. 
d.  Abscess can be treated by aspiration , incision and drainage. 
e.  Smoking cessation.  
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3.SCLEROSING ADENOSIS:  
         Disorder of either proliferative or the involutional phase of breast cycle (or 
both).  Proliferation of glandular and stromal element causing enlargement with 
distortion of lobular unit. 
         Incidence is at 30-50 yrs of age(child bearing and perimenopausal 
women). Uncommon cause of a breast lump and raise the suspicion of 
carcinoma. Smooth,relatively mobile mass, frequently painful. Occasionally it 
can be a cause of mastalgia rather than mass. 
         Diagnosis made by histology or mammography. It has similar type of fine 
stipled calcification as in  carcinoma which makes it difficult in differentiating. 
Treatment: 
Excision to rule out carcinoma. 
4. EPITHELIAL HYPERPLASIA:  
It is more common in premenopausal period and regress spontaneously after 
menopause. Disease end of the spectrum is atypical ductal and lobular 
hyperplasia  and involvement of 
terminal ductal lobular unit(TDLU) is commonly associated with malignancy. 
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OLDER CLASSIFICATION OF BENIGN BREAST DISORDERS: 
A. INFLAMMATORY CONDITIONS : 
Acute abscess 
Chronic mastitis 
Fat necrosis 
Gangrene 
Tuberculosis 
Filariasis 
B. MAMMARY DYSPLASIA : 
Cysts 
Adenosis 
Lobular hyperplasia 
Fibrosclerosis 
Sclerosing adenosis 
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C. BENIGN BREAST TUMOURS : 
Fibroadenoma 
Cystosarcoma phyllodes 
Intraductal papilloma 
Intraductal hyperplasia 
D. BENIGN LESIONS  WITH PROBABLE INCREASED RISK OF 
CANCER : 
Gross cystic disease 
Papillary apocrine changes 
Apocrine metaplasia 
Epitheliosis and atypia 
Atypical lobular hyperplasia 
Multiple intraductal papilloma 
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CULLIN WERREN CLASSIFICATION
30 
: 
                                                 Benign breast diseases 
                  ↙                                              ↓                                         ↘ 
            a)    Epithelial                       b) connective tissue                      c) mixed 
                    ↓  ↓                                             ↓ 
1)Duct papilloma                               1)neurofibroma                          
1)Fibroadenoma 
2)pure adenoma                               2)Lipoma                                      2)cyst 
adenoma 
OTHER BENIGN BREAST DISORDERS: 
NIPPLE INVERSION: 
           Disorder of development of terminal ducts that results in interference 
with protrusion of ducts and areola and hypothesis proposed for its association 
with increased incidence of duct ectasia. 
          Surgical correction not advised in this patients. Reassurance is enough.  
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MAMMARY DUCT FISTULA : (Zuska disease) 
Other infrequent terms by which the above conditions referred is squamous 
metaplasia of the lactiferous, mammillary fistula. Atkins(1955) was the first 
person to describe fistulas of the lactiferous ducts but first reported by 
Zuska(1957) and the first person to recognise the association between fistula 
and duct ectasia was Sandison nad Wallen. 
The sequence of event that occurs as follows : 
Nipple inversion→ terminal duct obstruction→ recurrent subareolar 
abscess→mammary duct fistula. 
        As per the most recent view, the periductal mastitis/duct ectasia is the 
cause underlying. Inversion of the nipple has been the most important aetiology 
for mammary fistula. Patient present to the physician with history of 
intermittent nipple discharge and also with subareolar mass and characterised by 
its chronicity.  
EPITHELIAL HYPERPLASIA OF PREGNANCY : 
          The marked hyperplasia of duct epithelium give rise to papillary 
projection which inturn can give rise to bilateral bloody nipple discharge. 
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BENIGN DUCT PAPILLOMA : 
           It is a common condition that occurs as a result of disorder of cyclical 
epithelial activity. It present as a  definite  subareolar mass with serous or 
bloody or sanguinous  nipple discharge with short duration of history.  
3 TYPES: 
1. Solitary intra ductal papilloma 
2. Multiple intraductal papilloma 
3. Papilloma of nipple : 
                   a) Papillary adenoma (common type) 
                   b) Solitary papilloma 
CYSTOSARCOMA PHYLLODES : 
            Muller coined  the  term “Cystosarcoma phyllodes”, this tumour is 
neither cystic nor sarcomatous and thus the designation should be abandoned in 
favour of the a whitish, fibrous appearance. In Phyllodes , the tumour activity 
varies from benign to locally aggressive to metastatic tumours. 
             Similar to FA, phyllodes is a fibro epithelial tumour. Its  been  
differentiated from FA by its unique stroma(cellular and sarcoma like)  and also 
malignant nature is determined by the same stromal cell. Phyllodes are rapidly 
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growing, non-capsulated but still it is a well circumscribed tumour. They don‟t 
invade the skin usually, instead pressure necrosis occurs due to its rapid growth.   
     
FIG.4:  Cystosarcoma phyllodes with pressure necrosis 
 
 
 
 FIG.5:  cystosarcoma phyllodes 
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 CLASSIFICATION : 
  Phyllodes tumour is classified based on Degree of stromal cell atypia, number 
of mitoses, tumour margin characteristics, abundance of stromal cells as 
follows. 
                   1.   Benign 
                    2.  Borderline  
                    3.  Malignant 
 BENIGN PHYLLODES : 
                    Clinically the breast lump appears to have smooth surface and 
defined borders. Histopathologically characterised by  hypocellular stroma with 
minimal nuclear atypia and low mitotic activity.  
          Approximately 5 - 25 percent of phyllodes tumors are described as 
malignant.  
Fewer than 20 percent of the malignant tumors metastasize. Metastases usually 
spread hematogenously to the lungs, pleura, or bone. Axillary lymphadenopathy 
are rare, if present indicates grave prognosis. 
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INVESTIGATION : 
         On mammography, phyllodes tumors appear as lobulated, round, or oval 
masses. Usually noncalcified and well circumscribed. In  ultrasonography, 
phyllodes tumors appear as well defined, solid masses with heterogeneous 
internal echoes  without posterior acoustic attenuation.  
           It is often difficult to distinguish between benign and malignant 
phyllodes tumors on the basis of sonographic or mammographic findings. In 
such a situation, T2-weighted MR images can be helpful. Phyllodes  tumors are 
usually identified as oval, round or lobulated masses, Circumscribed margins 
and homogeneous high signal intensity. 
          FNAC and core biopsy aid in diagnosis. Confirmatory diagnosis greater 
with histopathological examination of excisional biopsy.  
Management : 
Histological confirmation is necessary.  
Primary excision along with a normal tissue margin of 1cm is the treatment of 
choice, as the tumour does not  have a true capsule. 
For local recurrence, re-excision or simple mastectomy can be done.  
Poor results are obtained with chemotherapy and radiotherapy for recurrence or 
metastasis. 
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 Microscopy  : 
 Phyllodes tumour shows hypercellular stroma with pleomorphism where as the 
giant fibroadenoma shows hypocellular stroma, phylodes tumours are well 
demarcated but may invade the pseudocapsule. This explains the tendency for 
local recurrence following simple enucleation.  
The following hitological features are in favour of malignant phyllodes : 
1. higher mitotic index 
2. stromal component proliferation is higher compared to glandular component 
3. Cytologic atypia 
4. peripheral growth invasiveness with infiltration of the surrounding tissues 
ACUTE MASTITIS :   
          The condition develops when bacteria gain access to the breast tissue 
through the ducts. Usually develops during the early weeks of nursing. 
Staphylococcal infections induce single or multiple abscesses accompanied by 
typical inflammatory changes.   
BREAST ABSCESS: 
1. Lactating breast abscess 
2. Non -  lactating breast abscess 
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1. Lactating breast abscess : 
        It is caused by Staphylococcus aureus but can also caused by 
Staphylococcus epidermidis and Streptococci. The infection is attributed to 
abrasions or cracks of the nipple via which the organism gain entry to cause the 
disease.  In a lactating women, the suckling infant‟s oral flora gain its entry via 
crack nipple, multiply in stagnant milk and cause the disease. The mother 
presents with fever, pain, tenderness, swelling of affected breast. The 
fluctuation is an unreliable late sign.  
  FIG.6: Breast abscess 
Axillary lymph node enlargement is unusual. Clinically patient will be toxic and 
biochemically evident with leucocytosis. 
            Treatment  with antibiotics  followed by repeated aspiration  or incision 
and drainage of the abscess. Advise mother to stop breast feeding in the affected 
side and continue with normal breast. The infant is not harmed by certain 
antibiotics including flucloxacillin, co-amoxiclav and erythromycin, with in the 
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milk. Antibiotics that are contraindicated during lactation include tetracycline 
and ciprofloxacin. 
 FIG.7: Incision & drainage of Breast 
abscess 
                Kaur and Minocha V.R.
18
 in their review article summarize the 
treatment of breast abscess. A better personal and infant hygiene and early 
treatment with antibiotics can prevent occurrence of lactational breast abscess. 
Small breast abscesses can be managed conservatively, by repeated aspiration 
with oral antibiotics and large abscesses may necessitate incision and drainage. 
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 FIG.8:  placement of drain in breast 
abscess 
NON LACTATING BREAST ABSCESS : 
A)Periareolar infection : 
        Most common in younger and mean age is 32 year. The disease has been 
preceded by peridutal mastitis. The above condition should not be mistaken for 
duct ectasia as they are common in postmenopausal women and are of different 
entity.  
B)Peripheral non lactating breast abscess : 
        They are uncommon when compared to above described condition. 
Diabetes, rheumatoid arthritis and patient on steroid treatment are more likely to 
be associated with such type of breast abscess. But many manifested the disease 
without any prior factor. Most importantly, malignancy underlying has to be 
ruled out with consideration to her age. Staphylococcus aureus is the causative 
factor.  
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Usually seen among premenopusal and postmenopausal women. 
 FIG.9: periareolar breast abscess 
ADENOMAS 
          Adenomas of the breast are well defined tumors. Histopathologically 
characterised by sparse epithelial elements with inconspicuous stroma. The 
latter one help to  differentiate  from fibroadenomas, as stroma is the major 
constituent. 
 Though the condition is more of pathological diagnosis, practically they can be 
categorised as follows : 
             1. Tubular adenomas  
             2. Lactating adenomas 
1.Tubular Adenomas : 
         It occurs commonly in  younger age group. Clinically present as a lump in 
the breast or as a nodule in the breast with well circumscribed borders, firm 
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consistency and freely mobile and often diagnosis of fibroadenoma is clinically 
made.  
 Microscopic examination : 
        Adenomas separated from the adjacent breast tissue by a psuedocapsule 
and composed of proliferation of uniform, small tubular structures with a scanty 
intervening stroma. 
2.Lactating Adenomas (Nodular Lactational Hyperplasia) 
      As the name suggest, the breast disease occurs in relation to pregnancy and 
lactation. Clinically present as lump in the breast with well defined margin and 
exhibit lobulation. On palpation, it is soft. Some believe that lactating adenoma 
develops due to superimposed lactational changes on a pre-existing tubular 
adenoma 
Epitheliosis : 
It‟s a pathological diagnosis.Epithelial proliferation in small ducts, ductules and 
lobules. 
INVESTIGATIONS:  
      To increase the positive predictive value, combination of diagnostic tests 
used. Ultimately the chance of missing truly positive cases can be significantly 
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minimised. The same concept is applied during the evaluation of cases of breast 
lump on the basis of triple assessment. 
      Breast lump assessment necessitate multi-disciplinary team approach of 
clinician, radiologist & pathologist and technical staff too. 
       The role of combined assessment in cases of BBD, is to exclude cancer, to 
make a definitive diagnosis of benign conditions, to detect  clinicaly impalpable 
lesion,  image guided intervention and to consider conservative management in 
deserved cases thereby avoiding unwanted surgical modality of treatment and 
for  follow up.   
 Triple assessment include  
1. Clinical examination of the patient 
2. mammography and/or ultrasound of breast 
3. FNAC/Histopathological diagnosis  
Mammography: 
        Mammography either confirm or denies the clinical diagnosis. The 
suspected lesion is visualised its presence can be demonstrated. A positive 
predictivity of this imaging modality is 95 percent. Its role is utilised in critical 
situations where the physician is in doubt of his clinical diagnosis in 
differentiating the benign from cancerous lesions of the breast.
29
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Mammography signs of BBD: 
Primary signs : 
1. the outline of the lesion being smooth 
2. the shape of the lesion being either ovoid/lobulation/defined 
circumference 
3. homogenous lesion with hypodensity / transradiant lesions 
4. calcification that are coarse and smooth 
Secondary signs : 
1. Transient fat halo 
2. Displacement of surrounding breast parenchyma  
3. Multiplicity and laterality(bilateral) of the lesion 
4. Normal blood flow within the lesion 
5. Dimension of radiologically assessed > clinically measured lesion  
       Even some of the benign disorder can mimic carcinoma due to „distortion 
of the architecture‟ of the breast that include biopsy scar, radical scar, sclerosing 
adenosis and fat necrosis. Microcalcification can be present in microcyst, 
papilloma, sclerosing adenosis, epithelial hyperplasia with fine ones and in 
fibroadenoma with coarse calcifications.  
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Ultrasound : 
        The investigation can distinguish between a solid and cystic lesion. 
FNAC  :                           
         FNAC is a quick and cost effective investigation which gives a 
preliminary histological lead, based on which one can plan either an open 
biopsy or medical line of treatment. 
          The major advantage of FNAC with quick reporting helps the physician 
for immediate alleviation of the patients fear and avoidance of unnecessary 
surgery in patients with benign breast disease while at same time detecting all 
patients with breast carcinoma. 
Open biopsy : 
It is used to both confirm the diagnosis and also for therapy in small 
lesions(benign). 
APPLICATION OF PATHOLOGICAL CLASSIFICATION IN BENIGN 
BREAST DISEASES : 
        In a patient point of view, once benign  lump is removed, the next concern 
for her will be for fear of recurrence or chance of developing cancer breast in 
near future. For a surgeon, the  histopathological report help to determine the 
confirmation of diagnosis, completeness of the treatment undertaken, of 
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paramount importance is to ascertain the risk of malignancy in near future. As a 
result , further follow up and evaluation  with relevant investigation if needed  
can be planned well of. 
       The lack of consensus between pathologist with respect to various 
microscopic features  is important, as they are ascertained  in determining the 
cancer risk in feature note. The initial and the only study undertaken to solve 
this issue by Page and co-workers and proposed the more practically applicable 
pathological classification of BBD, forms the basis for consensus statement of 
American cancer society. 
       Cancer risk is defined as a liability to develop breast cancer in the ensuing 
10 – 20 years, compared with developed in age matched women who have had 
no breast biopsy. 
The following pathological classification help us in ascertaining the risk : 
1. There is no risk attributed for adenosis(scleroisng or florid), apocrine 
metaplasia, macro and/or micro cysts, duct ectasia,fibroadenoma, fibrosis, 
hyperplasia(miid 2 – 4 epithelial cells), mastitis, periductal mastitis, squamous 
metaplasia. The above disorders  are classified as non proliferative lesions. 
  2. Moderate hyperplasia(florid, solid or papillary) and papilloma with a 
fibrovascular core ascertained to have slightly increased risk of about 1.5 – 2 
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times. They are characterised by proliferative disease without atypia  and 
absolute life time risk is approximately 5 – 7 percent 
        Its been believed  that  family history of carcinoma breast in a first degree 
relative will boost up the risk of cancer espcially in women with proliferative 
lesions without atypia. But there is no evidence to support the above issue. 
3.The atypical ductal and lobular hyperplasia has been ascertained to have 
moderately increased risk of about 5 times. This lesions are  characterised by 
proliferative disease with atypia.  Irrespective of the disease per se to laterality, 
both breast are at risk in their life time risk is 13 – 17percent. 
       Page et al
16
 reported that the risk of cancer attributed by a positive family 
history in cases of atypical hyperplasia is increased by two times than estimated. 
       Breast hyperplasia without a family Cancer Detection Demonstration 
Project (BCDDP) study also observed similar results. 
 4. To assign risk, insufficient data proposed for solitary papilloma or lactiferous 
sinus  and Radical scar lesion. 
        Lynn C.Hartmann et al stratified the increased risk associated with 
proliferative lesion with atypia and final results have revealed that family 
history is an independent risk factor
19
.   
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        HRT increases the risk of breast cancer development but not so observed in 
womens   with proliferative breast disease with or without atypia. 
STANDARDISATION OF HISTOLOGIC CRITERIA : 
        Ultimately the benign breast diseases are diagnosed by the pathologist and 
that‟s been the final. To differentiate Benign lesion from carcinoma in situ in 
breast, even the experienced pathologist cannot reproduce  the results 
consistently. To sort out this problem, many studies were undertaken. One such  
study suggest that for diagnosing proliferative breast lesions, a  standard  
histological  criteria among  pathologists is necessary thereby reducing the  inter 
observer variability. By reducing the inter observer variability, could aid in a 
consistent result.    
FUTUROLOGY: 
        Active effort is also being made to identify the biological markers/genetic 
markers from benign breast biopsies. The limitations of morphology was 
considered in this subject and studies are in the vogue to identify the role of 
biological or genetic markers especially its application in differentiating  
atypical ductal hyperplasia and low-grade DCIS.  Unfortunately, they share a 
common immunophenotypes. Cyclin D1, messenger RNA, is the one and only 
marker found helpful in differentiate the DCIS(low grade) from ductal 
hyperplasia with atypia. 
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       Markers under study in this regard, includes estrogen receptor, 
angiogenesis, p53 expression, and HER-2/neu expression. In a recent study it 
has been observed that irrespective of the status of hyperplasia association with 
atypia in a  benign breast biopsies, its association with angiogenesis has found 
to increase the cancer risk. Similarly, risk of breast cancer has been increased in 
a benign breast tissue containing p53  protein accumulation as per current study.                               
        To conclude, the role of biological and molecular markers in ascertaining 
the cancer risk in a cases of benign breast diseases has not completely 
established and still considered as an area of active investigation. 
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AIMS AND OBJECTIVES 
RATIONALE BEHIND THE STUDY:  
                   Benign breast disease which cause a great deal of discomfort(both 
physical and mental) to the patient, who have doubt that it could be malignant, 
which has to be ruled out. The need for study is to analyse the spectrum of 
benign breast disease with respect to age, sex, mode of presentation, clinical 
features and management.  
 AIMS & OBJECTIVES : 
1. To study the patients presenting with various types of benign breast 
diseases. 
2. To study the association of benign breast disease with menstrual status, 
marital status, parity, family history & personal history. 
3. To study the common presentation of benign breast diseases. 
4. To correlate the results of FNAC with that of histopathology in all the 
post operative cases. 
5. To study the treatment modalities in benign breast diseases. 
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MATERIALS AND METHODS 
               It is a prospective study aimed at evaluation of cases of benign breast 
diseases in Tirunelveli medical college & hospital from the period of feb 2011-
july 2012 over a period of 18 month. 
SOURCE OF DATA: 
TIRUNELVELI MEDICAL COLLEGE,HOSPITAL,TIRUNELVELI 
DESIGN OF STUDY: 
Prospective study 
PERIOD OF STUDY : 
18 MONTHS 
SAMPLE SIZE : 
109 cases of benign breast diseases proven histopathologically. 
METHOD OF COLLECTION OF DATA : 
             Study group comprises of 109 female patients with benign breast 
disease admitted in Tirunelveli medical college and hospital during the period 
of 18 months. Patients clinically diagnosed as having BBD are admitted for 
further evaluation. After obtaining an informed written consent from the patient 
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, detailed history and clinical examination will be done as per my proforma 
designed. The proforma designed in the questionarre form. With the aid of 
routine investigations and investigations specific to the disease per se are also 
supplemented to confirm the diagnosis. The management will be decided 
according to the provisional diagnosis made after the investigations. The 
histopathological report  followed up. Finally, histopathologically proven cases 
of BBD will be included in the study with consideration to inclusion and 
exclusion criteria. If needed secondary analysis of medical records of these 
patient will be used to fulfil the missed and remaining data. Pathology report of 
all these patient collected from my collobarating department. The proformas are 
completed and finally compiled data are to be profiled.  
INCLUSION CRITERIA : 
 1. Females > 12 years 
2. Patients admitted with a provisional diagnosis of benign breast disease.  
3.  Patients who are found to have benign breast tumors on clinico-pathological 
examination. 
 EXCLUSION CRITERIA : 
 1. Females < 12 years 
2. Patients diagnosed to have malignancy during evaluation  
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3. Pregnant  females 
4. Males 
COLLOBRATING DEPARTMENT : 
DEPT OF PATHOLOGY 
STASTICAL METHOD:  
The data represented in tables, bar charts, graphs.  
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RESULTS OF THE STUDY 
        The present study includes proven cases of 109 patients with benign breast 
disease in Tirunelveli medical college and hospital over a period of 18 months 
and the data are profiled. 
A) DISTRIBUTION  OF BENIGN BREAST DISEASES IN THE STUDY 
GROUP 
TABLE 4 : Distribution of BBD in the study group 
   Disease Cases % 
fibroadenoma 72 66.1 
FCD 11 10.1 
Phyllodes 15 13.8 
Tubular Adenoma 5 4.6 
Breast Abscess 5 4.6 
Epitheliosis 1 0.9 
Total 109 100.0 
   
 
           In the study group, among the cases of BBD, Fibroadenoma was more 
prevalent  that accounts for about 72 cases(66%) which is followed by 
phyllodes occurring in 15 patients(13.8%), fibrocystic diseases in about 11 
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cases(10.1%), 10 cases of tubular adenoma & breast abscess with equal 
sharing,1 case of epitheliosis was recorded. 
 
 
       FIG.10: Distribution of BBD  
 
 
          Out of 72 cases of fibroadenoma, 8 cases were giant fibroadenoma. 
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B) DISTRIBUTION OF BBD AMONG VARIOUS AGE GROUP 
FIG.11: Age wise distribution of BBD 
 
FIG.12: Graphical representation of age distribution 
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C) MODE OF PRESENTATIONS IN THE STUDY GROUP 
TABLE 5: Various modes of presentations of BBD in study group 
FIG.13: Chief complaints in  study group 
 In study group, majority complained of lump association with pain were 58 
cases and 51 cases with lump alone. Among the present study, painless lump  
being a chief complaint in most  of the patients with fibroadenoma  & in tubular 
      Chief Complaints Total % 
Lump 51 46.73 
Lump + Pain 58 
53.22 
Total 109 100 
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adenoma  whereas lump associated with pain is been the predominant complaint 
among the FCD & phyllodes patient in study  group.   
D) DURATION OF SYMPTOMS 
TABLE 6: Study of Duration of symptoms   
  
         
      
Month FA FAD Phyllodes TA 
Br. 
Abscess 
Epitheliosis Total % 
< 1 month 7 2 3 4 5 0 21 19.3 
1 - 6 month 51 6 7 0 0 1 65 59.6 
7 - 12 month 9 2 4 1 0 0 16 14.7 
> 12 months 5 1 1 0 0 0 7 6.4 
Total 72 11 15 5 5 1 109 100.0 
 
            In the present study,duration of symptoms studied in which most of 
cases presented witth duration ranging between 1 – 6 months(59.6%). 
            Out of 65 cases(59.6%) almost majority  presented  between 1 – 6 
months with 51 cases comprised by fibroadenoma patients,9 cases between 7 – 
12 months,7 cases  in a period of less than a month of the same in the study 
group. 
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             Out of 21 cases(19.3%),2 cases among FAD, 3 cases among 
phyllodes,4 cases among tubular adenoma and all 5 cases of breast abscess 
presented in a period of less than a month. 
E) FAMILY HISTORY:  
          Family history of breast lesion in 6 cases of fibroadenoma was 
obtained.Out of them. 5 cases gave family history in their siblings  and one case 
in her mother.  
F) PAST HISTORY:  
          4 cases of fibroadenoma had history of operated for breast lump in their 
past and all these cases had their prior lump only in their contralateral breast. 
G) RECURRENCE :  
           In the present study, 2 cases of recurrence BBD observed .One case of 
fibroadenoma and  other was a phyllodes. 
H) MENSTRUAL HISTORY : 
           Menstrual irregularity were present only in few cases . 6 cases of 
postmenopausal women had BBD. One case of phyllodes was observed in a 
female patient(13 years) who has not attained her menarche. 
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I) PARITY :  
           Most of the benign breast disease occur after second child birth 
J)OCP : 
            In the present study, OCP usage noted in  7 cases of BBD. 
K) MENOPAUSE:  
            6 CASES observed. 
L)  DIET : 
             In the present study, majority were consuming mixed diet(94.5%) and 
vegetarian accounts for 5.5% of BBD. 
M) LATERALITY IN THE STUDY GROUP :  
TABLE 7: Laterality among study group 
 Side Total % 
L 63 57.8 
R 41 37.6 
B/L 5 4.6 
Total 109 100.0 
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             In the study group,most of the cases occurred on left breast,63 
cases(57.8%) than right breast with 41 cases(37.6%)  recorded. Bilateral 
involvement noted in 5 cases(4.6%). 
            Unilateral involvement of BBD is noted with few cases of bilateral 
involvement also observed.   
 
FIG.14: Laterality of BBD in study group 
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J) QUADRANTS INVOLVED 
TABLE 8 : Study of quadrant Involvement in BBD 
 Quadrant Frequency % 
UO 64 58.7 
UI 20 18.34 
LO 14 12.84 
LI 7 6 
Central 4 3 
Total 109 100.0 
             
 
FIG.15: Distribution of BBD among quadrant   
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             In the present study its observed, BBD predominantly occurred in upper 
outer quadrant  in 64 cases(58.7%), followed by 20 cases(18.34%) occurred in 
upper inner quadrant, 14 case(12.84%)  in lower outer quadrant, 7 cases noted 
in lower inner and  4 cases in central quadrant. 
             In the study BBD involved predominantly the upper outer 
quadrant,considerable no of cases noted followed by upper inner> lower 
outer>lower inner >central quadrant of breast. 
K)  STUDY OF DIMENSIONS IN THE STUDY GROUP 
Table.8: Study of dimension of lesions   
DISEASE <2CMS 2-5CMS >5CMS TOTAL 
FA 2 58 12 72 
FCD - 10 1 11 
PHYLLODES - 3 12 15 
TA 1 3 1 5 
BR. ABSCESS - 1 4 5 
EPITHELIOSIS - 1 0 1 
TOTAL 3 76 30 109 
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FIG.16: Dimensions in BBD 
 
L) CONSITENCY & MOBILITY: 
Most of the cases were in firm in consisteny with varying mobility 
demonstrated.  
 
M) SENSITIVITY AND SPECIFICITY OF DIAGNOSIS:  
 
CLINICOPATHOLOGICAL CORRELATION : 
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TABLE 9: COMPARISON OF CLINICAL DIAGNOSIS WITH H/P/E  IN 
FIBROADENOMA 
CLINICAL 
DIAGNOSIS 
FIBROADENOMA 
AS H/P/E 
FIBROADENOMA 
AS NOT H/P/E 
TOTAL 
POSITIVE 67 22 89 
NEGATIVE 5 15 20 
TOTAL 72 37 109 
Sensitivity : 93.05% 
Specifity :40.54% 
Positive predictive value : 75.2% 
Negative predictive value : 75% 
In cases of fibrocystic disease, the sensitivity and specifity of the clinical 
examination are as follows: 
Sensitivity :  45.45% 
Specificity : 4.5% 
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CYTOHISTOPATHOLOGICAL CORRELATION IN CASES OF 
FIBROADENOMA : 
Table 10: COMPARISON OF FNAC IN CONSISTENT H/P/E 
FNAC CONSISTENT 
WITH FA AS 
H/P/E 
INCONSISTENT 
WITH FA AS H/P/E 
TOTAL 
POSITIVE 65 23 88 
NEGATIVE 4 17 21 
TOTAL 69 23 109 
 
Sensitivity : 93.05% 
Specifity :40.54% 
Positive predictive value : 75.2%,  
Negative predictive value : 75%. 
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N) TREATMENT OF BBD IN THE STUDY GROUP 
Table.11: REPRESENTATION OF TREATMENT OF BBD IN THE STUDY 
GROUP 
DISEASE EXCISION WLE MASTECTOMY I&D 
FA 72 - - - 
FCD 11 - - - 
PHYLLODES 9 5 1 - 
BREAST 
ABSCESS 
- - - 5 
TUBULAR 
ADENOMA 
4 1 - - 
EPITHELIOSIS 1 - - - 
TOTAL 97 6 1 5=109 
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HISTOPATHOLOGY : 
1) Out of 15 cases of phyllodes, 
                                Benign – 2 
                                Borderline  - 1 (recurrent case) 
                                Low grade – 9 
                                Intermediate grade – 2 
                               High grade -2 
        2) Fibroadenoma with focal duct epitheliosis, noted in 3 cases. 
       3) Fibroadenoma with FCD was reported in a case of 39 years female. 
       4) One interesting case of benign phyllodes recorded in a 13 year female 
who has not attained menarche. Provisional diagnosis of fibroadenoma was 
made and FNAC supported the same. Excision of the lump on H/P/E reported as 
benign phyllodes. 
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                   DISCUSSION 
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DISCUSSION 
             The present study was conducted among 109 female patients of BBD in 
TVMCH from feb 2011 – july 2012 in order to profile the pattern of BBD in all 
its comparable aspects. All available literature on BBD were reviewed in detail 
in study group and the following observations were made. 
Table 12: Comparison of present study of BBD 
DISORDER PRESENT 
STUDY 
SANDHYA 
P.IYER(21) 
RANGABHASHYAM 
BASHYAM 
SUSHILA 
KHANNA(20) 
FIBROADENOMA 66.1% 35% 56.7% 40.8% 
FIBROCYSTIC  
DISEASE 
10.1 28.3%   14.2% 13.8% 
BREAST ABSCESS 5% 15% 7.9% - 
MASTITIS  8.3% 2.7% - 
OTHER MASS 6% 5%   
PHYLLODES 13.8%  2.3% 13.8% 
 
In study group, fibroadenoma was the most common BBD observed(66.1%). 
Our observation from the study was consistency was with the authours too. The 
next common disease was phyllodes followed by Fibroadenosis with 
Fibrocystic disease .  
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           A retrospective study  of 22 years stated that fibroadenoma of the breast 
was the commonest lesion followed by cystosarcoma phyllodes and fibrocystic 
disease is consistent with study group.
22
 
  Cases of Tubular Adenoma and Breast abscess has  also been reported in study 
group .  
  
Table13: COMPARISION OFAGE GROUPS INVOLVED IN BBD 
AGE PRESENT 
STUDY 
SANDHYA 
P.IYER
21
(%) 
SUSHILA 
KHANNA
20
(%) 
SOJI.F.OLUWOLE 
STUDY
23
(%) 
 
<20 23.9% 15.2 25.28 23.13 
21-30      33.9% 38 40.06 33.13 
31-40 22.9% 35 19.56 20 
41-50 16.5% 11.8 9.98 15.62 
>50 2.7% - 4.32 8.13 
                            
           The single best indicator of the probable underlying pathology of a breast 
mass or breast lump is the age of the patient. Most of the patients were in active 
reproductive years(20 -40 years) and the finding coincides with the occurrence 
of aberrations in most active years of womens life.  Occurence of BBD  is also 
observed  in extremes of age thereby no age is immune to BBD. 
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FIG.17: Comparison of age group in BBD  
 
         In study group, the youngest patient was 13 years and the eldest was 65 
yrs. In Indian study on BBD at Varanasi
23
,  the maximum incidence was in the 
age group of 21 – 30 years(43%). This finding correlates with the present study. 
        Fibroadenomas mostly observed in earlier age group whereas FCD are 
predominantly observed among 20 – 40 year age group and it depicts the fact 
they are variants of repeated cyclical changes in the form of menstruation, 
pregnancy and lactation. 
Table 14: COMPARISON OF COMMON PRESENTATION OF BBD 
          In study group, the most common presentation as lump associated with 
pain is observed in  63.8% respectively. In the study compared, the most 
common presentation was painless lump was the major complaint. 
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FIG.18: Comparison of common presentations in BBD 
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Table 15:  COMPARISON OF DURATION OF SYMPTOMS 
DURATION PRESENT STUDY 
<1 MONTH 19.3% 
1-6 MONTHS 59.6% 
7-12 MONTHS 14.7% 
>1YEAR 6.4% 
 
        In the study group, the common presentation of symptoms within 6 
months. These patients who presented earlier helped us not only in treating 
them at early stage of the disease, but also to alleviate the patient fear to exclude 
cancer.  
FAMILY HISTORY & OCP : 
         Role of both were controversial in literature in causation of BBD. Study 
group does not support the influence in causation. 
PAST HISTORY :   
          4 Cases had past history of lump breast operated in contralateral side in 
cases of FA. 
MENSTRUAL HISTORY :  
           The relation of irregularity seen in few cases, whether this carries any 
significance is inconclusive.  
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PARITY AND LACTATION :  
         When breast has understandably gone through the cycle of menstruation, 
pregnancy and lactation repeatedly after second child birth where BBD is 
common. 
          In lactating females, the most common lesions include breast abscess 
because act of suckling introduces infections.   
MENOPAUSE : 
          In the study group,  menopause is not an exception to BBD ( 6 cases). 
DIET HISTORY :  
           Majority of the cases were consuming mixed diet in study group that 
probably support the role of diet in occurrence of BBD in the present study.  
 
LATERALITY : 
Table 16: COMPARISON OF DISTRIBUTION AMONG SIDE 
SIDE PRESENT 
STUDY(%) 
SOJI.F.OLUWOLE 
STUDY(%)
23 
ETIM.E.ONUKAK 
(%)
25
 
RIGHT 37.6 45 43.8 
LEFT 57.8 41 48 
B/L 4.6 14 8.2 
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In the present study, left side was the commonest side involvement. The side of 
breast involved showed no significant difference between either right or left,but 
commonly lesion involvement is unilateral rather than categorising  to 
side.Bilateral invovement were reported in 5 cases.(25) 
QUADRANT : 
 TABLE 17: COMPARISON OF QUADRANTS INVOLVED IN BBD 
QUADRANT PRESENT 
STUDY(%) 
SOJI.F.OLUWOLE 
STUDY(%)
23
 
PREMILA 
DESOSA ROCHA 
ETAL 1997
26
 
UO 58.71 41 45.2 
UI 18.34 19 7.6 
LO 12.84 14 5.2 
LI 6% 7 4.4 
CENTRAL 3% 4 30.2 
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FIG.19: Comparison of BBD among quadrant 
 
 
                              In the present study,the most common involved was upper 
and outer quadrant of the breast. This is also in consistent among the Soji F. 
Oluwole
23
 & Premila Desouza Rocha et al study
26
. It is been explained that the 
proportion of breast tissue in respective quadrants coincides with the occurrence 
of breast diseases which was proposed  in malignancy may also be applied to 
benign disease also. 
SIZE OF THE LESIONS : 
 In the present study,more number of lesion varied from 2 – 5 cm(69.72%) 
constituting its average size with overall size ranges from 2 – 10 cm. In 
Soji.F.Oluwole(23) study more number of lesions varied from 1cm to 10cms. 
80% of the fibroadenoma size ranged from 2 -5 cm,corresponds to what is 
described in literature.   
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Usually, the largest lesion in size was clinically diagnosed as phyllodes tumour. 
CONSISTENCY AND MOBILITY : 
        As per study group, most of the BBD are firm. Classical mobility in cases 
of fibroadenoma demonstrated only in 1/5
th
 of the cases. 
PROVISIONAL DIAGNOSIS :  
         When the size of the lesion is more, clinical diagnosis was favoured 
towards phyllodes and most of them found to be giant FA of breast and vice 
versa too. 
SENSITIVITY & SPECIFITY : 
          Clinico pathological correlation in cases of fibroadenoma showed 93.5% 
sensitivity, 40.54%   specificity, PPV – 75.2% and NPV - 75 %. 
           Cytohistopathological correlation in cases of FA showed 94.2% 
sensitivity, 42.5% specificity, PPV- 5.79 %, NPV – 57.5  %. 
TREATMENT : 
        All patients in study group were managed surgically.  
         In study group, Excision biopsy was the treatment provided for all cases of 
fibroadenoma , fibrocystic disease, tubular adenomas.  Depending upon size and 
preoperative investigations, phyllodes tumour treated by wide local excision and 
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mastectomy for a case of recurrent phyllodes. All our cases of breast abscess 
were treated by incision & drainage procedure. 
       Though in some patients of BBD, conservative treatment advised, removal 
of disease was wanted by the patient for social reason & fear. 
       The positive predictive value of diagnostic method can be increased with 
triple assessment to increase the accuracy so that a more truly positive cases 
would be brought into light and a more appropriate management can be ensued.   
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CONCLUSION 
         Fibroadenoma is the commonest BBD followed by phyllodes, Fibrocystic 
diseases of the breast. Most common BBD in Indian subcontinent  includes  
fibroadenoma followed by fibrocystic disease. Benign breast disease commonly 
occurs during the 2nd and 3rd decade and fibroadenoma being the common 
BBD in the same age group. FCD commonly seen among 3
rd
 decade and 
phyllodes commonly observed among  4
th
 decade. It has been noted that no age 
is immune to BBD. Most BBD observed after second child birth. During 
lactation, breast abscess cases noted. Role of family history and OCP s in 
causation of BBD is not significant in the study group. 
Most common presentation of BBD was lump in association pain. 
Most of them presented  with short duration of complaint. So the early 
presentation could partially be due to the greater awareness of the disease of the 
breast and fear that breast lump could be malignant.  
Unilateral involvement of breast lesion was common, mostly involved the upper 
outer quadrant and usually a solitary lesion.  
Average size of the lesion was about 2 – 5 cm. Most of them were firm with 
classical mobility demonstrable  in fibroadenoma cases, only in 1/3
rd
 of the 
cases. 
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 All patients in study group were managed surgically. Though the present trend 
of conservative management has reduced number of surgical procedures. 
However in view of the anxiety regarding symptoms, distance to be travelled, 
poor socioeconomic conditions leading to difficulty in follow up, so patients opt 
for an early surgical method of resolution of symptoms and fear of malignancy. 
Final diagnosis was relayed upon pathological examination of the specimen and 
further follow up of the patient planned accordingly.  
The sensitivity and specificity of clinical examination was 93.5% and 40.54%  
and that of FNAC was 94.2% and 42.5% in cases of FA. 
 One interesting case of benign phyllodes recorded in a 13 year female who has 
not attained menarche. 
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SUMMARY 
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SUMMARY 
Most common BBD was Fibroadenoma and predominantly affecting the 2
nd
   
and 3
rd
  decade of life. Specific age of occurrence among  the various BBDs is 
noted and also coincides with cyclical changes of menstruation, parity, lactation 
and involution, as an aberration. Lump associated with pain is the most common 
presenting complaint. Majority of  BBD presented after second parity and 
infection cases presented in relation to lactation. The role of family history and 
OCP usage is still to be settled or in dispute. BBD favoured unilateral 
involvement and majority affecting the upper outer quadrant.  
           All cases of BBD in the study was managed surgically. The specificity of 
clinical examination in diagnosing various BBD is fairly accurate. This explains 
the role of Triple assessment to increase the positive predictive value. 
         Because of our cultural places importance on breast and fuels a pervasive 
fear of breast cancer, individuals with breast masses spark strong concern. 
Patient benefit from early consultation with physician to address their concerns.  
Management of BBD is an important component in clinical practice. Self 
esteem is often much improved after surgery. Women should still be 
encouraged to represent to the service if any new mass appear in future. 
                “ Breast awareness is a goal of breast health movement .”                                                  
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PROFORMA 
Name:                        I.P.no: 
Age:                           unit    : 
Sex:                           D.O.A: 
Religion                     D.O.S: 
Occupation                D.O.D: 
Residence 
Chief complaints: 
Breast lump:side  
                     duration 
                     pain 
Nipple changes:discharge/recent changes/indrawn  
Any other swelling 
Past history:H/Osimilar swelling 
History of drug intake:drug details: 
                                   duration 
Menstrual history:age of menarche: 
                             cycles:  
                             menopause: 
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                             mastslgia  
Marital history:married/unmarried 
Past obstetric history;no of children: 
                          age at each childbirth: 
Family history:H/Obreast swelling in other family members: 
       General physical examination: 
Vital signs: 
Local examination: 
inspection:symptomatic breast examination: 
           In sitting posture,arms by the side of the body 
              nipple:position/size/shape/surface/discharge/indrawn/retraction 
              areola: 
              skin over the breast: 
Arms raised above the head: 
Movement of breast: 
Leaning forward: 
Palpation: side  
                quadrant: 
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                 size: 
                 shape: 
    surface/margin: 
         consistency: 
            Skin fixity: 
Fixity to underlying structure: 
Examination of lymph node:axillary  
                                          supraclavicular  
Examination of opposite breast and axilla: 
Systemic examination:CVS  
                                     RS 
                              ABDOMEN 
PROVISIONAL DIAGNOSIS: 
INVESTIGATION: 
URINE A/S/D: 
CBC: 
BL.S       ,U-         ,Cr-         . 
Blood grouping n typing: 
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LFT: 
Chest X ray:                   USG:abdomen n pelvis 
FNAC 
BIOPSY 
FINAL DIAGNOSIS: 
TREATMENT: 
                     Surgery details:incision: 
                                         procedure: 
                                         post op: 
                                
 
 
 
 
 
 
 
                                           
 
 
 
 
 
[Type text] 
 
MASTER CHART 
KEYWORDS 
U -  unmarried 
L -  lump 
L+P -  lump+pain 
M -  month 
D -  days 
R -  recurrence 
+  pasthistory 
R -  regular menstruation 
IR -  irregular 
EN/EX -  enucleation/excision 
LG/IG/HG -  lowgrade/intermediate/highgrade 
R - right  
L - left 
U0 -  upper outer 
LO -  lower outer 
UI - upper inner 
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LI - lower inner 
C -  central 
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